DrugsNews.net

Drugs Xagena

Xagena Mappa
Medical Meeting
Reumabase.it
Farmaexplorer.it

Search results for "Entresto"

The FDA ( Food and Drug Administration ) has approved Entresto ( Sacubitril / Valsartan ) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death ...


Entresto ( Sacubitril / Valsartan ), previously known as LCZ696 has been approved by Health Canada for the treatment of heart failure with reduced ejection fraction ( HFrEF ) in patients with NYHA Cla ...


The European Commission ( EC ) has approved Entresto ( Sacubitril / Valsartan ) for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction ( HFrEF ). Ent ...


The fixed-dose combination of Sacubitril and Valsartan ( Entresto ) has been approved for adults with symptomatic chronic heart failure with reduced ejection fraction. The German Institute for Quali ...